Outcomes of short‐duration antiviral prophylaxis for hepatitis C positive donor kidney transplants-Reference-Cited by-同舟云学术

Outcomes of short‐duration antiviral prophylaxis for hepatitis C positive donor kidney transplants

Published:2021-07-26 Issue:11 Volume:21 Page:3734-3742
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American J Transplantation

Author:

Gupta Gaurav¹²^ORCID,Yakubu Idris³,Zhang Yiran⁴,Kimball Pamela²,Kang Le⁵,Mitchell Kimberly²,Ijioma Stephen⁶,Carroll Norman⁶,Patterson Julie⁶,Shinbashi Meagan¹,Kumar Dhiren¹^ORCID,Moinuddin Irfan¹^ORCID,Kamal Layla¹,King Anne¹²,Bhati Chandra²^ORCID,Levy Marlon²^ORCID,Cotterell Adrian²,Khan Aamir²,Sharma Amit²,Sterling Richard²⁷

Affiliation:

1. Division of Nephrology Virginia Commonwealth University School of Medicine Richmond Virginia USA

2. Division of Transplantation Hume‐Lee Transplant CenterVirginia Commonwealth University School of Medicine Richmond Virginia USA

3. Virginia Commonwealth University School of Pharmacy Richmond Virginia USA

4. Global Health Economics & Outcomes Research Indivior Inc. Richmond Virginia USA

5. Department of Biostatistics Virginia Commonwealth University Richmond Virginia USA

6. Department of Pharmacotherapy and Outcomes Science Virginia Commonwealth University School of Pharmacy Richmond Virginia USA

7. Section of Hepatology Virginia Commonwealth University School of Medicine Richmond Virginia USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16747

Reference30 articles.

1. The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States

2. High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department

3. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis

4. Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients

5. Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilising organs from hepatitis C virus PCR‐positive donors in Western Australia;Internal Medicine Journal;2024-03-07

2. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline;Annals of Internal Medicine;2023-12

3. Ultrashort direct-acting antiviral prophylaxis for human immunodeficiency virus and hepatitis C virus coinfected donor positive to human immunodeficiency virus-positive kidney transplants;American Journal of Transplantation;2023-12

4. Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial;Annals of Internal Medicine;2023-12

5. Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants;Journal of the American Pharmacists Association;2023-11